{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T10:59:45Z","timestamp":1791975585058,"version":"4.4.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T00:00:00Z","timestamp":1696204800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","award":["R355-2020-949"],"award-info":[{"award-number":["R355-2020-949"]}],"id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018693","name":"Horizon Europe","doi-asserted-by":"publisher","award":["765657"],"award-info":[{"award-number":["765657"]}],"id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003554","name":"Lundbeck Foundation","doi-asserted-by":"publisher","award":["R355-2020-949"],"award-info":[{"award-number":["R355-2020-949"]}],"id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003554","name":"Lundbeck Foundation","doi-asserted-by":"publisher","award":["R383-2022-306"],"award-info":[{"award-number":["R383-2022-306"]}],"id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004836","name":"Independent Research Fund Denmark","doi-asserted-by":"publisher","award":["8021-00173B"],"award-info":[{"award-number":["8021-00173B"]}],"id":[{"id":"10.13039\/501100004836","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005302","name":"Onassis Foundation","doi-asserted-by":"publisher","award":["F ZP 014-1\/2019-2020"],"award-info":[{"award-number":["F ZP 014-1\/2019-2020"]}],"id":[{"id":"10.13039\/501100005302","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Pharmacological Sciences"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.tips.2023.09.012","type":"journal-article","created":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T05:54:36Z","timestamp":1698731676000},"page":"978-990","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Ligand selectivity hotspots in serotonin GPCRs"],"prefix":"10.1016","volume":"44","author":[{"given":"Icaro A.","family":"Simon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walden E.","family":"Bj\u00f8rn-Yoshimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasper","family":"Harps\u00f8e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stylianos","family":"Iliadis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Svensson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders A.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4299-7561","authenticated-orcid":false,"given":"David E.","family":"Gloriam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tips.2023.09.012_bb0005","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0028-3908(94)90060-4","article-title":"The molecular evolution of G protein-coupled receptors: focus on 5-hydroxytryptamine receptors","volume":"33","author":"Peroutka","year":"1994","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.tips.2023.09.012_bb0010","series-title":"Handbook of Behavioral Neuroscience","first-page":"3","article-title":"Evolution of serotonin: sunlight to suicide","author":"Azmitia","year":"2020"},{"key":"10.1016\/j.tips.2023.09.012_bb0015","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1146\/annurev.med.60.042307.110802","article-title":"The expanded biology of serotonin","volume":"60","author":"Berger","year":"2009","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.tips.2023.09.012_bb0020","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.pharmthera.2016.12.005","article-title":"Current and novel insights into the neurophysiology of migraine and its implications for therapeutics","volume":"172","author":"Akerman","year":"2017","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.tips.2023.09.012_bb0025","doi-asserted-by":"crossref","first-page":"3732","DOI":"10.2174\/1381612821666150605111236","article-title":"Atypical antipsychotics and inverse agonism at 5-HT2 receptors","volume":"21","author":"Sullivan","year":"2015","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.tips.2023.09.012_bb0030","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.tips.2013.08.001","article-title":"From obesity to substance abuse: therapeutic opportunities for 5-HT2C receptor agonists","volume":"34","author":"Higgins","year":"2013","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.tips.2023.09.012_bb0035","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1007\/s00213-017-4545-5","article-title":"A short history of the 5-HT(2C) receptor: from the choroid plexus to depression, obesity and addiction treatment","volume":"234","author":"Palacios","year":"2017","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.tips.2023.09.012_bb0040","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.2174\/138920112800784880","article-title":"Serotonin receptors as targets for drugs useful to treat psychosis and cognitive impairment in schizophrenia","volume":"13","author":"Meltzer","year":"2012","journal-title":"CPB"},{"key":"10.1016\/j.tips.2023.09.012_bb0045","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.2147\/NDT.S263424","article-title":"Serotonin type 6 and 7 receptors as a novel therapeutic target for the treatment of schizophrenia","volume":"16","author":"Tsegay","year":"2020","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.tips.2023.09.012_bb0050","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.pbb.2011.03.022","article-title":"Drug targets for cognitive enhancement in neuropsychiatric disorders","volume":"99","author":"Wallace","year":"2011","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.tips.2023.09.012_bb0055","doi-asserted-by":"crossref","first-page":"3348","DOI":"10.3390\/molecules26113348","article-title":"Modulation of serotonin receptors in neurodevelopmental disorders: focus on 5-HT7 receptor","volume":"26","author":"Lee","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.tips.2023.09.012_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108233","article-title":"Targeting the 5-HT system: potential side effects","volume":"179","author":"Hoyer","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.tips.2023.09.012_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108155","article-title":"Central 5-HT receptors and their function; present and future","volume":"177","author":"Sharp","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.tips.2023.09.012_bb0070","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1177\/0269881107082944","article-title":"Asenapine: a novel psychopharmacologic agent with a unique human receptor signature","volume":"23","author":"Shahid","year":"2009","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.tips.2023.09.012_bb0075","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1126\/science.1232807","article-title":"Structural basis for molecular recognition at serotonin receptors","volume":"340","author":"Wang","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.tips.2023.09.012_bb0080","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.ejmech.2018.04.010","article-title":"Structural insights into serotonin receptor ligands polypharmacology","volume":"151","author":"Podlewska","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.tips.2023.09.012_bb0085","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1016\/j.molcel.2022.05.031","article-title":"GPCRs steer Gi and Gs selectivity via TM5-TM6 switches as revealed by structures of serotonin receptors","volume":"82","author":"Huang","year":"2022","journal-title":"Mol. Cell"},{"key":"10.1016\/j.tips.2023.09.012_bb0090","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/s41586-021-03376-8","article-title":"Structural insights into the lipid and ligand regulation of serotonin receptors","volume":"592","author":"Xu","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.tips.2023.09.012_bb0095","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1126\/science.abl8615","article-title":"Structure-based discovery of nonhallucinogenic psychedelic analogs","volume":"375","author":"Cao","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.tips.2023.09.012_bb0100","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.cell.2018.01.001","article-title":"5-HT(2C) Receptor structures reveal the structural basis of GPCR polypharmacology","volume":"172","author":"Peng","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.tips.2023.09.012_bb0105","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1126\/science.1232808","article-title":"Structural features for functional selectivity at serotonin receptors","volume":"340","author":"Wacker","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.tips.2023.09.012_bb0110","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s41593-021-00971-w","article-title":"Structure-based design of a novel third-generation antipsychotic drug lead with potential antidepressant properties","volume":"25","author":"Chen","year":"2022","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.tips.2023.09.012_bb0115","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.cell.2020.08.024","article-title":"Structure of a hallucinogen-activated Gq-coupled 5-HT(2A) serotonin receptor","volume":"182","author":"Kim","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.tips.2023.09.012_bb0120","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.cell.2016.12.033","article-title":"Crystal structure of an LSD-bound human serotonin receptor","volume":"168","author":"Wacker","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.tips.2023.09.012_bb0125","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1016\/j.neuron.2022.08.006","article-title":"Signaling snapshots of a serotonin receptor activated by the prototypical psychedelic LSD","volume":"110","author":"Cao","year":"2022","journal-title":"Neuron"},{"key":"10.1016\/j.tips.2023.09.012_bb0130","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.tips.2014.11.001","article-title":"Generic GPCR residue numbers - aligning topology maps while minding the gaps","volume":"36","author":"Isberg","year":"2015","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.tips.2023.09.012_bb0135","doi-asserted-by":"crossref","first-page":"4429","DOI":"10.1021\/jm900319e","article-title":"Definition of the G protein-coupled receptor transmembrane bundle binding pocket and calculation of receptor similarities for drug design","volume":"52","author":"Gloriam","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.tips.2023.09.012_bb0140","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1021\/jm9700575","article-title":"New chemical descriptors relevant for the design of biologically active peptides. A multivariate characterization of 87 amino acids","volume":"41","author":"Sandberg","year":"1998","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.tips.2023.09.012_bb0145","doi-asserted-by":"crossref","first-page":"479","DOI":"10.2174\/156802610791111533","article-title":"Recent advances in the discovery of selective and non-selective 5-HT(1D) receptor ligands","volume":"10","author":"Ward","year":"2010","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.tips.2023.09.012_bb0150","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1021\/acsomega.9b03430","article-title":"Dibenzofuranylethylamines as 5-HT(2A\/2C) receptor agonists","volume":"5","author":"Yempala","year":"2020","journal-title":"ACS Omega"},{"key":"10.1016\/j.tips.2023.09.012_bb0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0209804","article-title":"5-HT2 receptor binding, functional activity and selectivity in N-benzyltryptamines","volume":"14","author":"Toro-Sazo","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.tips.2023.09.012_bb0160","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1124\/jpet.107.133348","article-title":"Lorcaserin, a novel selective human 5-hydroxytryptamine2C agonist: in vitro and in vivo pharmacological characterization","volume":"325","author":"Thomsen","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tips.2023.09.012_bb0165","unstructured":"Smith, B. et al. Arena Pharmaceuticals Inc. Benzazepine derivatives and methods of prophylaxis or treatment of 5ht2c receptor associated diseases, US2007142357."},{"key":"10.1016\/j.tips.2023.09.012_bb0170","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1021\/acschemneuro.3c00267","article-title":"Structure-activity assessment and in-depth analysis of biased agonism in a set of phenylalkylamine 5-HT(2A) receptor agonists","volume":"14","author":"Pottie","year":"2023","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.tips.2023.09.012_bb0175","doi-asserted-by":"crossref","first-page":"12031","DOI":"10.1021\/acs.jmedchem.2c00702","article-title":"Discovery of beta-arrestin-biased 25CN-NBOH-derived 5-HT(2A) receptor agonists","volume":"65","author":"Poulie","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.tips.2023.09.012_bb0180","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/s41594-018-0116-7","article-title":"Structural determinants of 5-HT(2B) receptor activation and biased agonism","volume":"25","author":"McCorvy","year":"2018","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.tips.2023.09.012_bb0185","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1038\/s41422-021-00527-4","article-title":"Structural basis for recognition of anti-migraine drug lasmiditan by the serotonin receptor 5-HT(1F)-G protein complex","volume":"31","author":"Huang","year":"2021","journal-title":"Cell Res."},{"key":"10.1016\/j.tips.2023.09.012_bb0190","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.35946","article-title":"Cryo-EM structure of the adenosine A(2A) receptor coupled to an engineered heterotrimeric G protein","volume":"7","author":"Garcia-Nafria","year":"2018","journal-title":"eLife"},{"key":"10.1016\/j.tips.2023.09.012_bb0195","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/nchembio.2527","article-title":"Structure-inspired design of beta-arrestin-biased ligands for aminergic GPCRs","volume":"14","author":"McCorvy","year":"2018","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.tips.2023.09.012_bb0200","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/s41594-018-0180-z","article-title":"Structures of the 5-HT(2A) receptor in complex with the antipsychotics risperidone and zotepine","volume":"26","author":"Kimura","year":"2019","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.tips.2023.09.012_bb0205","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/s41594-022-00796-6","article-title":"Inactive and active state structures template selective tools for the human 5-HT(5A) receptor","volume":"29","author":"Zhang","year":"2022","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.tips.2023.09.012_bb0210","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-68355-x","article-title":"The discovery of a new antibody for BRIL-fused GPCR structure determination","volume":"10","author":"Miyagi","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tips.2023.09.012_bb0215","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/sj.bjp.0705950","article-title":"New insights into the human 5-HT4 receptor binding site: exploration of a hydrophobic pocket","volume":"143","author":"Rivail","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.tips.2023.09.012_bb0220","doi-asserted-by":"crossref","first-page":"8223","DOI":"10.1073\/pnas.1700891114","article-title":"Structural insights into the extracellular recognition of the human serotonin 2B receptor by an antibody","volume":"114","author":"Ishchenko","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tips.2023.09.012_bb0225","doi-asserted-by":"crossref","first-page":"4344","DOI":"10.1021\/jm020153s","article-title":"Lysergamides of isomeric 2,4-dimethylazetidines map the binding orientation of the diethylamide moiety in the potent hallucinogenic agent N,N-diethyllysergamide (LSD)","volume":"45","author":"Nichols","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.tips.2023.09.012_bb0230","doi-asserted-by":"crossref","first-page":"D395","DOI":"10.1093\/nar\/gkac1013","article-title":"GPCRdb in 2023: state-specific structure models using AlphaFold2 and new ligand resources","volume":"51","author":"Pandy-Szekeres","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.tips.2023.09.012_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.sbi.2023.102560","article-title":"The impact of cryo-EM on determining allosteric modulator-bound structures of G protein-coupled receptors","volume":"79","author":"Zhang","year":"2023","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.tips.2023.09.012_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108242","article-title":"Allosteric modulation of GPCRs: from structural insights to in silico drug discovery","volume":"237","author":"Persechino","year":"2022","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.tips.2023.09.012_bb0245","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nature12595","article-title":"Structural basis for modulation of a G-protein-coupled receptor by allosteric drugs","volume":"503","author":"Dror","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.tips.2023.09.012_bb0250","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1038\/s41467-023-37808-y","article-title":"Constrained catecholamines gain \u03b2(2)AR selectivity through allosteric effects on pocket dynamics","volume":"14","author":"Xu","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tips.2023.09.012_bb0255","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/s41589-022-01247-5","article-title":"Structural basis of efficacy-driven ligand selectivity at GPCRs","volume":"19","author":"Powers","year":"2023","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.tips.2023.09.012_bb0260","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1111\/febs.15826","article-title":"Allosteric communication regulates ligand-specific GPCR activity","volume":"288","author":"Ma","year":"2021","journal-title":"FEBS J."},{"key":"10.1016\/j.tips.2023.09.012_bb0265","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1111\/bph.15811","article-title":"Community guidelines for GPCR ligand bias: IUPHAR review 32","volume":"179","author":"Kolb","year":"2022","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.tips.2023.09.012_bb0270","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1124\/pr.118.016790","article-title":"Biased receptor signaling in drug discovery","volume":"71","author":"Kenakin","year":"2019","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.tips.2023.09.012_bb0275","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.mce.2019.01.018","article-title":"Binding kinetics of ligands acting at GPCRs","volume":"485","author":"Sykes","year":"2019","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.tips.2023.09.012_bb0280","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/s41586-018-0241-9","article-title":"Cryo-EM structure of the serotonin 5-HT(1B) receptor coupled to heterotrimeric G(o)","volume":"558","author":"Garcia-Nafria","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.tips.2023.09.012_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111211","article-title":"Molecular insights into the regulation of constitutive activity by RNA editing of 5HT(2C) serotonin receptors","volume":"40","author":"Gumpper","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.tips.2023.09.012_bb0290","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.bbrc.2023.05.126","article-title":"Structural insight into the selective agonist ST1936 binding of serotonin receptor 5-HT6","volume":"671","author":"Pei","year":"2023","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.tips.2023.09.012_bb0295","article-title":"5-Hydroxytryptamine receptors (version 2019.4) in the IUPHAR\/BPS Guide to Pharmacology Database","volume":"2019","author":"Yocca","year":"2019"},{"key":"10.1016\/j.tips.2023.09.012_bb0300","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/s41586-022-05258-z","article-title":"Bespoke library docking for 5-HT(2A) receptor agonists with antidepressant activity","volume":"610","author":"Kaplan","year":"2022","journal-title":"Nature"}],"container-title":["Trends in Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614723002146?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614723002146?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T20:52:15Z","timestamp":1777495935000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165614723002146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":60,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S0165614723002146"],"URL":"https:\/\/doi.org\/10.1016\/j.tips.2023.09.012","relation":{},"ISSN":["0165-6147"],"issn-type":[{"value":"0165-6147","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ligand selectivity hotspots in serotonin GPCRs","name":"articletitle","label":"Article Title"},{"value":"Trends in Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tips.2023.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}